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Introduction
Chronic kidney disease (CKD) is one of the leading global health problems due to its increasing prevalence and associated complications (1) . According to a recent systematic review and meta-analysis, the prevalence of CKD has been estimated between 11% to 13% worldwide (2) . This review highlighted that information on earlier CKD stages is still limited despite a higher prevalence. This is of particular concern in developing countries (3) . In Iran, different studies have provided varying estimates of the disease in adults ranging from 12.6% to 23.7% (4) (5) (6) . In a study of Iranian children, a higher prevalence of CKD was found compared to western countries (7) . Adding to this existing CKD burden is a growing trend in coming years, which has been predicted in a population based modeling study (8) . Still, many aspects of CKD care are poorly understood due to limitations in existing data. For example, it is not completely clear how care is accessible for different groups with regards to gender, ethnicity and socioeconomic status or how progressive the disease is across different regions of the country. To be able to keep up with the growing CKD trend, accurate and up to date patient data is required in all stages for informed policy making and management planning, as acknowledged by scholars in the field (9) .
Disease registries have a great potential to provide reliable observational data for a specific group of patients (10) .
Their implementations have been associated mostly with a positive impact on healthcare processes and outcomes (11) . Furthermore, such registries can potentially become an efficient policymaking tool (12) . The oldest renal registry was founded in Europe in 1964 (13) . In a recent systematic review, 144 renal registries were identified worldwide with varying aims, structures, and CKD patients targeted (14) . Noteworthy is that a majority of these registries were based in developed countries and focused on end stage renal diseases (ESRD). Unfortunately, the number of renal registries in developing countries was not prominent in this review. In Iran, the transplant office in the Iranian Ministry of Health and Medical Education has taken the initiative to establish a transplant registry, which includes kidney transplantations. A comprehensive renal registry that also includes the early stages of CKD, however, has not so far been in place at neither national nor local levels. Therefore, to address this deficiency, a renal registry development project was started in the West Azerbaijan province in 2016. This article describes the initiatory yet crucial steps taken to establish such a registry at our healthcare context. As a fundamental step in designing any disease registry (10), we first and foremost aimed to define the objectives of founding a renal registry in our context, to identify opportunities, threats and challenges along the way, as well as to extract its essential minimum data set (MDS).
Methods
This was a mixed method study conducted in two phases: 1) a qualitative study using interviews and document analysis, and 2) a quantitative study using a modified Delphi survey. The details of these two, including the process to extract MDS for a CKD registry, are described below. The study started late fall 2016 and lasted till late summer 2017. Before the start of the study, it was approved by the research ethics committee of UUMS. Formal written consent was not sought from the participants because acceptance of our invitation for an interview and also submission of completed questionnaires by the survey participants were taken as implied consent. Even so, before any data collection, we informed our participants about the confidentially of any information provided by them.
Phase 1: qualitative study
In this part of the study, we used interviews and document analysis. We interviewed 17 key experts with the knowledge of merits and pitfalls of CKD care in our context. As individuals with different types of knowledge, expertise and skills are involved in CKD care, we invited representatives of all key stakeholders i.e., physicians, nurses and data managers to participate in our study (please see the result section). Our interview participants were identified through a purposive sampling after interviewing their first group. During interviews, we focused on the questions to define the objectives of such a registry in our healthcare context, and to identify opportunities and possible threats and challenges along the way. We were interested to analyze how these issues might affect establishing a given CKD registry. More than one interview was held with some of our participants but in different occasions. Interviews were in-depth, semi-structured, one-on-one and face-to-face. Interviews lasted 30-45 minutes each. After ensuring the confidentiality of information provided, 12 interviews were voice recorded and transcribed verbatim and analyzed before conducting a new one. During the other interviews, interview notes were concurrently taken and their contents were approved by the participants. This helped to organize the questions for the consequent interviews and to check the validity of our preliminary interpretations with the participants. The interviews were continued until data saturation was achieved.
We analyzed our qualitative data using a "grounded theory" approach (15) . In this method, data was coded around the areas of our research interests and aims until the main themes emerged. The overall data analysis for the present study was conducted by the first and the corresponding authors independently and the resulting themes were discussed in multiple meetings till consensus was reached.
Phase 2: quantitative study using a modified Delphi survey
We reviewed the literature and also the official websites of leading CKD registries already identified in (14) , in both international and national levels of developed and developing countries, and extracted their common data elements whenever they were publicly available (for example please see (13, (16) (17) (18) (19) (20) (21) (22) (23) (24) ). To cover all CKD stages, we were interested in all renal registries encompassing either earlier, later or entire CKD stages. To the list of extracted common data elements, we added the data items of interest for our main stakeholders or future users (i.e., nephrologists, nurses and care managers) especially those data items mentioned as essential for data management tasks. By incorporating these two sources, we developed the first version of a questionnaire. The questionnaire consisted of data items organized in 10 categories in English. In front of each item, it was documented which country's renal registry included that item. Participants were asked to rate the necessity of inclusion of an item in the MDS using a three-point likert scales i.e., "very important=2", "important=1" and "not important=0".
In order to select MDS, we used a modified Delphi survey defined as "Delphi rounds plus a physical meeting" (25) . This method has already been used successfully to develop a MDS for clinical fields (26, 27) . In round 1, we distributed the questionnaire to 14 physicians, nurses and managers in nephrology care. Following review of the first round's responses, it was decided that two slightly different questionnaires would be distributed in the second round to target pediatrics and adult patient registrations individually. This was mainly because of the sake of greater clarity and some slightly differing information needs of our clinicians for pediatrics and adult patient populations.
Round 2 of the Delphi was conducted through sending an email survey to key informants working in other medical universities and inviting them to rate the data elements. A sampling was not used for this purpose and the inclusion in this invitation was merely based on our familiarity with participants.
3. Data analysis
In both rounds, percentages and mode values were used for outcome measures as indicators of agreement on the three-point scales. Decision to include an item was based on achieving consensus when greater than 60% of respondents rated that item as "very important=2" or "important=1" indicating a clear majority. If greater than 60 % of participants scored an item as "very important" with mode 2, that item was considered mandatory in our intended CKD registry. The remaining selected items, which commonly had mode 1, were considered voluntary. Comments provided by the respondents in the questionnaires were also analyzed thematically. Quantitative statistical analyses of the rating of data items were undertaken with the SPSS software version 16. Meetings were held with senior adult and pediatric nephrologists to discuss the results of analysis and to make decisions on the final data categories and items.
Results

Qualitative results
In total, 26 interviews were conducted with 17 key experts who were 5 adult and 2 pediatrics nephrologists, 2 kidney transplant surgeons, 4 nephrology nurses in the nephrology and kidney transplant wards, 4 experts from Urmia University of Medical Sciences' vice chancellor of clinical affairs and the charity organization for supporting patients with kidney disease. Table 1 provides details of these interviews.
[Inset Table 1 here]
Objectives and expected benefits of a CKD registry
The interviews revealed that all our interviewees commonly believed that developing and establishing a CKD registry would be a pivotal step to provide a qualitative, coordinated CKD care. We identified the following perceived goals that can be achieved by establishing a viable CKD registry. In the views of our participants, especially physicians, the most notable goal with a CKD registry would be collecting accurate data and information of CKD patients in different stages, particularly those in earlier stages before they develop into ESRD. The following quote spells the point out: Having accurate data would provide physicians with the opportunity to track and monitor the progress of CKD patients more closely and actively in the early stages. They told us the tales of multiple patients who had been in earlier CKD stages but due to different reasons nephrologists had lost track of patients' renal function trajectory and then these patients came back for follow-up visits in their final CKD stages. Our nephrologists expected that recalling such lost to follow up patients to receive evidence-based CKD care would be a much easier task by registering and actively chasing them. This way, clinicians might be able to prevent or at least to delay the rapid progression to ESRD saving hundreds of kidneys. In order to have a thorough overview on the CKD patients in our region, it was proposed that all patients would be targeted for registration regardless of their stages except when they do not give consent for registry or receive kidney transplantation.
Our interviewees stated that having reliable data in such registry will have multiple benefits. It will facilitate organizing and also managing a more coordinated CKD care by informing the main stakeholders such as nephrologists, nephrology nurses, internal medicine specialists and family physicians, governmental and nongovernmental organizations as well as policy makers. It can also aid clinicians to control CKD complications such as cardiovascular diseases, anemia and metabolic bone disorders before they become urgent or irreversible. Next, conducting research on epidemiology or the clinical aspects of CKD care in our setting will be promoted. On that account, the main CKD causes and also contributing factors on its progression trajectory can be better known. Last but not least, such information would inform policy makers' decisions regarding health system planning and capacity building for CKD care as one of our interviewees remarked on this issue:
"…the financial data we receive are accurate because we have their official documents; but about the other [patients' non-financial, clinical] data, they are often incomplete because we do not have the necessary infrastructure for reliable data collection, although some are collected on line… Because our planning is based on the data which is sent to us, therefore the [clinical] recorded data is very important for us." (A registry manager, 20 th of December,
2016)
Challenges and opportunities
Our results also showed that although a CKD registry was considered instrumental in achieving the above mentioned goals and benefits, our participants were deeply concerned about a number of challenges that may undermine the efforts for the registry establishment or threaten its success and maintenance. The most frequently mentioned challenge in our study was the shortages of financial and human resources to cover up required workload.
As emerged, it seemed a prerequisite to recruit designated individuals with information technology knowledge to collect necessary data from various sources and then populate the registry with those data. If data entry tasks are to be assigned to clinicians, then their motivations for cooperation should properly be addressed. For example, it was suggested that financial or other ways of compensations for this increased workload could be considered such as decreased shift work. It should also be noted that in addition to the nephrologists and nurses in academic hospitals and clinics, other clinicians such as internal medicine specialists or even family physicians are currently involved in providing CKD care in the community. In order to have their contribution in a given CKD registry, attractive secondary benefits either financial or non-financial might be compelling.
Moreover, in order to lessen data entry workload and make it a pleasing experience, it was advised that the data items and the efforts required for their entry should be kept as minimal as possible, particularly in early implementation stages. Next challenge highlighted by our participants was a fragile infrastructure to deploy the information and communication technology across the province for sharing data through a registry. In their views, a comprehensive single source of patient data is greatly lacking in the current healthcare system. Therefore, the data must be compiled from multiple sources and then should be validated by qualified individuals to be credible for clinical decisions and policy making purposes.
Alongside the above mentioned challenges, the following opportunities were also identified in the way of establishing a CKD registry for our setting: 1) ownership of the project by clinician leaders i.e., medical informaticians, nephrologists and transplant surgeons, 2) the focus and emphasis on collecting clinically relevant, rather than financial and administrative, data items aiming to promote a sustainable, qualitative CKD care, and 3) project alignment with the university's top research priorities and recent initiatives such as a large CKD screening project newly funded by the National Institute for Medical Research Development (NIMAD) of Iran.
Quantitative results
In total, 18 local and national experts in nephrology care participated in the Delphi survey. In the first round, from 14 invited participants, all completed the questionnaire (100% response rate). Eleven did so in the second round from which 4 were new participants all invited from other academic centers across the country (i.e., Tehran, Shiraz and Kermanshah universities of medical sciences). The majority of the survey participants were physicians (60%) and men (56%). All were experienced and key experts in their professions or managerial roles.
Data elements
The final validated data elements in our study were composed of 168 elements in 11 categories. These categories were consisted of demographics (16 elements), history of patient's CKD (11 elements), patient's other clinical histories (16 elements), patient family history (4 elements), current visits (17 elements), dialysis (34 elements), laboratory tests (46 elements), medications (17 elements), vaccinations (2 elements), ultrasonography results (3 elements) and mortality data (2 elements). Table 2 provides details of these data elements, their percentages and modes.
[Insert Table 2 here]
Discussion
In this study, we aimed to characterize the main objectives of founding a CKD registry in our healthcare context. Our participants' leading interest in establishing a registry was centered on providing a qualitative and coordinated care for their CKD patients, particularly those in earlier stages. They assumed that collecting and collating reliable information of CKD patients would enable conducting research and planning tailored prevention and management strategies in order to appropriately target in need patients. Using the Delphi survey, we defined a MDS to develop such a registry. The resulting MDS was more clinically oriented mainly because our participants put the quality of care at the center stage.
Despite the higher incidence and prevalence in earlier CKD stages, the majority of renal registries capture data of ESRD patients undergoing renal replacement therapy (RRT) (14) . The United States Renal Data System (USRDS) for ESRD patients has been operational since 1989 (28) . Till rather recently, however, this country lacked a comprehensive surveillance program to capture and track all aspects of CKD especially for those not yet receiving renal replacement therapy. Therefore, a CKD surveillance system was established to encompass all CKD stages aiming towards primary prevention, earlier detection and implementation of optimal disease management strategies in 2010 (29) . So far, very few registries have aimed to collect data on earlier CKD stages. In Australia, to address the data gap on earlier CKD stages, a surveillance program including a registry was established to include all public health renal practices across the province of Queensland (30) . To collect data of all CKD patients, the Indian Society of Nephrology embarked on developing a CKD registry as a nationwide data warehouse (23) . The Serbian pediatric CKD registry also included CKD stages 2-5 (24) . Similarly, in our study, registry aims were set to embrace all CKD stages of both adults and children patients with particular emphasis to capture events and monitor trends for patients in earlier stages enabling better care planning and policy makings for future.
It has been noted that the priorities of stakeholders are key for a renal registry to succeed (10, 31) . Outlining objectives with main stakeholders' full engagement is extremely important to fulfill their information needs, soundly. Following this approach, we defined a MDS that most commonly focused on capturing items that are of paramount importance from quality of care perspectives. Unavoidably, there are likely different perspectives among researchers and clinicians in other settings. For example, in some renal registries, it is necessary to capture financial data (see for instance (20, 32) ). In our qualitative study, the participants expressed their unwillingness for such data items to populate this registry. Because we put our clinicians' needs at the center stage, it is possible that our primary MDS used to initiate the registry is not comprehensive enough to address all the questions of researchers with broad research interests. Yet, such registries provide the basic information necessary to identify and recruit a representative research samples, as the experience of UK renal registry also shows (33) .
To gain success, MDS in patient registries should be flexible enough to incorporate new data elements based on evolving needs of clinicians and researchers (31) . For example, since conception of Korean renal registry in 1985, it has been evolving to include more and more clinically relevant data items, such as dialysis adequacy and lab data (34) . This was the case in USRDS as well, in which other objectives such as conducting economic and biomedical research were added later on in 1994 (35). We may also need to go through data revisions to capture additional information or to clean away superfluous data items after primary implementation phase. Fortunately, the in-house development of this registry makes its tailoring according to evolving needs more feasible. Moreover, in several renal registries, MDS of kidney transplantations were incorporated within ESRD registries (18-21). Nevertheless, we did not consider any MDS for kidney transplant in our study. This was mainly because of an already existing registry for transplantations in Iran. Therefore, we decided to avoid redundant or duplicate workload for our clinicians. It would be more productive if such registries with complementary aims could be linked to share data in future.
Information technology including registry systems has multiple benefits especially for chronic diseases (36, 37) .
Chronic care such as care delivered to CKD patients is highly collaborative. New models of care are needed for improved CKD care (38) . A renal registry can play an important role in the implementations of chronic care models for CKD (39) . Moreover, renal registries can facilitate establishing national CKD surveillance systems, as shown by successful initiatives in developed countries (29, 30, 40) . In a study of clinicians' attitudes towards a CKD registry in the United Sates, they believed that it has the potential to support their practice by identifying patients fallen out of care, recognizing CKD progression, tracking quality metrics and abnormal lab values, and providing evidence based decision supports (41) . Our participants had similar attitudes towards the potential benefits of a CKD registry.
Yet, they highlighted the workload of data collection and the required financial, technical and human recourses as potent inhibitors of a successful implementation if not considered and secured beforehand. These issues have played an important role in failure of a number of renal registries in developing countries (17) . We too should carefully consider the identified challenges and threads when we embark on full implementation and maintenance of such a registry in our healthcare context. It should be noted that, in the light of successful experiences of implementing national registries such as cancer and trauma in Iran, the prospect to secure the required resources from the Iranian ministry of Health is promising for CKD registry implementation.
1. Limitations
While we believe that our study is the first practical initiative to establish a CKD registry in our health care context, we recognize there were limitations. First, this research was conducted at provincial health care level. Therefore, further studies are needed for findings to be generalizable to the whole country. Although we believe the list of MDS identified in our study is inclusive and relevant from the quality of care perspectives, this data set may need to be vetted by a larger group of clinicians to be applicable nationwide. Further, we used the Delphi survey to reach a consensus on the data items. This method has been shown to be a useful method to define the objectives of such systems, their associated measures and data items (29) . However, one of its limitations is that minority opinions are marginalized. Finally, it is possible that important items were overlooked or not considered in our study. After initial implementation, we remain open to necessary modifications by collecting and collating suggestions for future possible MDS revisions.
Conclusion
We reported the initiatory steps taken to establish a CKD registry in an Iranian healthcare context. We focused on the information needs and priorities of our main stakeholders in order to define the objectives of establishing a CKD registry in Iran and its MDS. Our results showed that the quality of care perspectives influenced both the registry objectives and its MDS. Although, the required workload for clinicians was identified as the main challenge in this study, collecting minimally needed data longitudinally may benefit clinicians by addressing their main information needs about their patients. We hope this approach will facilitate its endorsement. Noteworthy that, following the current study, we developed a renal registry system that, by the time of this report, was in pilot phase at an academic renal center affiliated to Urmia University of Medical Sciences. We hope that the insights gained in this study will advance the efforts of our clinicians, researchers and policy makers for a qualitative CKD care. Managerial key informants in the vice chancellor of clinical affairs 2
Managerial key informants in the society of kidney patient support charity 2 
